Iressa Case Control Study in Japan

Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer

NCT00234442 ·Status: TERMINATED ·Phase: PHASE2

Iressa v BSC (Best Supportive Care) in First Line NSCLC

NCT00259064 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Management of Advanced Non-Small Cell Lung Cancer (NSCLC) and Clinical Outcomes in Patients Who Received Gefitinib in Thailand

NCT01130961 ·Status: COMPLETED

A Study of IRESSA Treatment Beyond Progression in Addition to Chemotherapy Versus Chemotherapy Alone

NCT01544179 ·Status: COMPLETED ·Phase: PHASE3

Assess the Efficacy, Safety and Tolerability of Gefitinib (Iressa® 250mg) as Maintenance Therapy in Locally Advanced or Metastatic (Stage IIIB/IV) Non Small Cell Lung Cancer (NSCLC)

NCT00770588 ·Status: COMPLETED ·Phase: PHASE4

Open Label Extension Study With Gefitinib (IRESSA™) for Completing Trial Patients Who May Benefit From Further Treatment

NCT00683306 ·Status: APPROVED_FOR_MARKETING

Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study

NCT00242801 ·Status: COMPLETED ·Phase: PHASE3

Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLC

NCT00234468 ·Status: TERMINATED ·Phase: PHASE3

Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00091156 ·Status: TERMINATED ·Phase: PHASE3

Iressa as Second Line Therapy in Advanced NSCLC-Asia

NCT00478049 ·Status: COMPLETED ·Phase: PHASE3

Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer

NCT00173875 ·Status: COMPLETED ·Phase: PHASE2

First Line IRESSA™ Versus Carboplatin/Paclitaxel in Asia

NCT00322452 ·Status: COMPLETED ·Phase: PHASE3

Observations From Long Term Responders in the Gefitinib (Iressa) Expanded Access Program (EAP)

NCT01103089 ·Status: COMPLETED

Gefitinib in Treating Patients With Previously Untreated Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00411047 ·Status: COMPLETED ·Phase: PHASE2

Phase II Iressa Versus Vinorelbine (INVITE)

NCT00256711 ·Status: COMPLETED ·Phase: PHASE2

Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00029003 ·Status: COMPLETED ·Phase: PHASE2

Descriptive Pharmacoepidemiological Study of Patients Treated With Iressa

NCT01448187 ·Status: COMPLETED

Iressa Re-challenge in Advanced NSCLC EGFR-mutated Patients

NCT02025218 ·Status: TERMINATED ·Phase: PHASE2

the Clinical Trial of Gefitinib(Non - Small Cell Lung Cancer)

NCT03264794 ·Status: UNKNOWN ·Phase: PHASE4

Phase I Study of Iressa and CRT/IMRT in Chinese Patients With IIIB/IV NSCLC After Failure of Platinum-Based Chemotherapy

NCT00497250 ·Status: UNKNOWN ·Phase: PHASE1

Phase II Iressa + Irradiation Followed by Chemo in NSCLC

NCT00333294 ·Status: COMPLETED ·Phase: PHASE2

Neoadjuvant IRESSA As Single Agent PreopTherapy for NSCLC With Molecular Correlates

NCT00104728 ·Status: TERMINATED ·Phase: NA

Study Evaluating Gefitinib (IRESSA®) in Subjects With Solid Malignancies That Are Locally Advanced, Recurrent or Metastatic

NCT00127829 ·Status: COMPLETED ·Phase: PHASE1

Intercalating and Maintenance Use of Iressa Versus Chemotherapy in Selected Advanced Non Small Cell Lung Cancer

NCT01404260 ·Status: COMPLETED ·Phase: PHASE3

Maintenance ZD1839 (IRESSA®) Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer

NCT00090675 ·Status: WITHDRAWN ·Phase: PHASE3